Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Gains from Investment Securities: 2010-2024

Historic Gains from Investment Securities for Rockwell Medical (RMTI) over the last 15 years, with Dec 2024 value amounting to $2.0 million.

  • Rockwell Medical's Gains from Investment Securities fell 11.43% to $124,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $446,000, marking a year-over-year decrease of 64.49%. This contributed to the annual value of $2.0 million for FY2024, which is 83.24% up from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Gains from Investment Securities is $2.0 million, which was up 83.24% from $1.1 million recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Gains from Investment Securities ranged from a high of $2.0 million in FY2024 and a low of $146,000 during FY2021.
  • Over the past 3 years, Rockwell Medical's median Gains from Investment Securities value was $1.1 million (recorded in 2023), while the average stood at $1.2 million.
  • As far as peak fluctuations go, Rockwell Medical's Gains from Investment Securities tumbled by 82.56% in 2021, and later spiked by 317.81% in 2022.
  • Yearly analysis of 5 years shows Rockwell Medical's Gains from Investment Securities stood at $837,000 in 2020, then plummeted by 82.56% to $146,000 in 2021, then soared by 317.81% to $610,000 in 2022, then soared by 80.00% to $1.1 million in 2023, then skyrocketed by 83.24% to $2.0 million in 2024.